Post-exposure treatments for Ebola and Marburg virus infections.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. An introduction to the Marburg virus vaccine consortium, MARVAC.PLoS pathogens · 2022
   Article
2. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.Human vaccines & immunotherapeutics · 2020
   Article
3. Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patients.EBioMedicine · 2020
   Article
4. Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacyBiosafety and health · 2019
   Review
5. Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs.The Journal of infectious diseases · 2018
   Article
6. The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection.The Journal of infectious diseases · 2018
   Article
7. Ebola Virus Infection in Commonly Used Laboratory Mouse Strains.The Journal of infectious diseases · 2018
   Article
8. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.The Journal of infectious diseases · 2018
   Article
9. Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures.The Journal of infectious diseases · 2018
   Article
10. Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.Viruses · 2018
    Article

Corrections and comments

• Erratum for
  Post-exposure treatments for Ebola and Marburg virus infections.2018

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.